PVA hydrogel sheet macroencapsulation for the bioartificial pancreas.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Transplantation Biology

Background:

• Islet transplantation is a promising therapy for type 1 diabetes.
• Current methods face challenges with cell survival and immune rejection.
• Macroencapsulation offers a potential solution for protecting transplanted islets.

Purpose of the Study:

• To develop and evaluate a novel sheet-type macroencapsulation device for rat islets.
• To assess the in vitro viability and function of encapsulated islets.
• To determine the in vivo efficacy of encapsulated islets in a mouse model of diabetes.

Main Methods:

• Rat islets were encapsulated using a freezing/thawing technique with 3% polyvinyl alcohol (PVA) in Euro-Collins solution with additives (PVA + EC).
• Control groups included islets encapsulated with PVA alone and free islets.
• In vitro assessments included islet recovery, morphology, insulin content, and glucose-stimulated insulin secretion.
• In vivo studies involved xenotransplantation into diabetic C57BL/6 mice, monitoring blood glucose levels.

Main Results:

• The PVA + EC encapsulation method significantly improved islet recovery and insulin content after 14-day culture compared to PVA alone.
• Only islets encapsulated with PVA + EC maintained normal morphology and insulin secretory function after 14 days.
• Xenotransplantation of PVA + EC encapsulated islets rapidly reduced blood glucose levels in diabetic mice and maintained them significantly lower than controls.

Conclusions:

• The developed freezing/thawing macroencapsulation technique using 3% PVA + EC is effective for preserving islet cell function.
• This method shows significant potential for successful islet xenotransplantation in treating diabetes.
• The PVA + EC formulation enhances islet survival and function, overcoming limitations of simpler encapsulation methods.